Tokyo, April 30 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060721) titled 'Real world investigation of Guselukmab induction and maintenance efficacy and safety for the patients with ulcerative colitis in Japanese tertiary center : REGALIA study' on April 30.
Study Type:
Observational
Primary Sponsor:
Institute - Saitama Medical University
Condition:
Condition - ulcerative colitis
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The purpose of this study is to establish the optimization of guselkumab treatment by prospectively examining the efficacy and safety, including the continuation rate, of guselkumab infusion and subcutaneous injec...